Provided by Tiger Trade Technology Pte. Ltd.

Cue Biopharma, Inc.

25.52
-2.3600-8.46%
Post-market: 25.520.00000.00%16:15 EDT
Volume:101.11K
Turnover:2.66M
Market Cap:185.39M
PE:-0.87
High:28.97
Open:27.48
Low:25.08
Close:27.88
52wk High:45.50
52wk Low:4.97
Shares:7.26M
Float Shares:6.85M
Volume Ratio:0.60
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.4600
EPS(LYR):-8.4244
ROE:-1603.48%
ROA:-172.66%
PB:80.25
PE(LYR):-3.03

Loading ...

Cue Biopharma, Inc. : Jefferies Adjusts Target Price to $66 from $4 to Reflect Reverse Stock Split

THOMSON REUTERS
·
Aug 28

U.S. Research Roundup-Dollar General, Palo Alto, Workday

Reuters
·
Aug 28

Adial Pharmaceuticals Posts Bigger-than-Expected Q2 Net Loss, Hurt by Acquisition Charges

Reuters
·
Aug 17

Cue Biopharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 15

Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Aug 15

Cue Biopharma Q2 EPS $-24.14

THOMSON REUTERS
·
Aug 15

Cue Biopharma Q2 FY26 Net Loss Widens to $153.07 Million; Revenue Rises 162.61% to $7.88 Million

Reuters
·
Aug 15

Cue Biopharma - Proposed Resale of up to 1,505,570 Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Aug 13

Cue Biopharma, Inc. Expected to Post a Loss of $1.69 a Share - Earnings Preview

Reuters
·
Aug 08

Cue Biopharma CFO James M. Ahlers Files Initial Beneficial Ownership Statement

Reuters
·
Aug 04

Press Release: Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission

Dow Jones
·
Aug 03

Cue Biopharma Files Form 3 for Chief Medical Officer, Head of R&D Dominique Borie

Reuters
·
Jul 16

Cue Biopharma Names Dominic Borie Chief Medical Officer, Head of R&D

Reuters
·
Jul 13

Cue Biopharma Appoints Dominic Borie, M.d., Ph.d., as Chief Medical Officer and Head of Research & Development

THOMSON REUTERS
·
Jul 13

Top Midday Gainers

MT Newswires Live
·
Jul 11

Cue Biopharma to sell 1.418M shares at $33.21 in private placement

TIPRANKS
·
Jul 10

Cue Biopharma Announces USD 50 Million Private Placement of Unregistered Shares and Pre-funded Warrants

Reuters
·
Jul 10

Cue Biopharma Announces $50.0 Million Private Placement

THOMSON REUTERS
·
Jul 10

Cue Biopharma Files for Shares Sale by Shareholder

MT Newswires Live
·
Jun 19

Cue Biopharma files to sell 551,724 shares of common stock for holders

TIPRANKS
·
Jun 19